Maze Therapeutics, Inc. (NASDAQ:MAZE) filed a Form 8-K with the Securities and Exchange Commission on February 04, 2026, disclosing a material event.
Maze Therapeutics, Inc.'s stock currently trades at $48.14 with a market capitalization of $1.9B. The Healthcare company's stock moved following the disclosure.